Massachusetts's General Hospital Study Demonstrates Prevencio's AI-driven HART CVE Blood Test Highly Accurate for Predicting Major Cardiac Events in Patients with...
KIRKLAND, Wash.--(BUSINESS WIRE)--Nov 3, 2022--
KIRKLAND, Wash.--(BUSINESS WIRE)--Nov 3, 2022--